WO2011130304A3 - Materials and methods for reliable measurement of blood volume - Google Patents

Materials and methods for reliable measurement of blood volume Download PDF

Info

Publication number
WO2011130304A3
WO2011130304A3 PCT/US2011/032158 US2011032158W WO2011130304A3 WO 2011130304 A3 WO2011130304 A3 WO 2011130304A3 US 2011032158 W US2011032158 W US 2011032158W WO 2011130304 A3 WO2011130304 A3 WO 2011130304A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood volume
methods
materials
individual
reliable measurement
Prior art date
Application number
PCT/US2011/032158
Other languages
French (fr)
Other versions
WO2011130304A2 (en
Inventor
Nathan J. Rice
Lennox Hoyte
Jianfeng Cai
Original Assignee
University Of South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of South Florida filed Critical University Of South Florida
Publication of WO2011130304A2 publication Critical patent/WO2011130304A2/en
Publication of WO2011130304A3 publication Critical patent/WO2011130304A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Abstract

The present invention concerns materials and methods for measuring the blood volume in a human or animal subject. The method of the invention involves determining the blood volume in the vasculature of an individual by determining the amount of detectable label in a sample of blood obtained from the individual after a volume of infusion media containing a known amount of the label has been introduced and allowed to be distributed and equilibrate within the individual's vascular system.
PCT/US2011/032158 2010-04-12 2011-04-12 Materials and methods for reliable measurement of blood volume WO2011130304A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32321710P 2010-04-12 2010-04-12
US61/323,217 2010-04-12

Publications (2)

Publication Number Publication Date
WO2011130304A2 WO2011130304A2 (en) 2011-10-20
WO2011130304A3 true WO2011130304A3 (en) 2012-03-01

Family

ID=44799279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/032158 WO2011130304A2 (en) 2010-04-12 2011-04-12 Materials and methods for reliable measurement of blood volume

Country Status (1)

Country Link
WO (1) WO2011130304A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502094A (en) * 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5529189A (en) * 1995-08-02 1996-06-25 Daxor Corporation Syringe assembly for quantitative measurement of radioactive injectate and kit having same
US5685302A (en) * 1994-11-22 1997-11-11 The Trustees Of Columbia University In The City Of New York Method for determining plasma volume, determination of blood volume thereby, and apparatus therefore
US6299583B1 (en) * 1998-03-17 2001-10-09 Cardiox Corporation Monitoring total circulating blood volume and cardiac output
US20090280055A1 (en) * 2007-03-29 2009-11-12 Heinrich-Heine Universitat Dusseldorf Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502094A (en) * 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5685302A (en) * 1994-11-22 1997-11-11 The Trustees Of Columbia University In The City Of New York Method for determining plasma volume, determination of blood volume thereby, and apparatus therefore
US5529189A (en) * 1995-08-02 1996-06-25 Daxor Corporation Syringe assembly for quantitative measurement of radioactive injectate and kit having same
US6299583B1 (en) * 1998-03-17 2001-10-09 Cardiox Corporation Monitoring total circulating blood volume and cardiac output
US20090280055A1 (en) * 2007-03-29 2009-11-12 Heinrich-Heine Universitat Dusseldorf Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods

Also Published As

Publication number Publication date
WO2011130304A2 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
MX2011013916A (en) Continuous analysis device and sample component control system.
WO2014066913A8 (en) Health diagnostic systems and methods
EP2073706A4 (en) System for analyzing tissue perfusion using concentration of indocyanine green in blood
WO2012006208A3 (en) Method and/or system for determining blood glucose reference sample times
WO2011123305A3 (en) Method and system to display analyte sensor data
WO2011133922A3 (en) Ultrasound based method and apparatus for stone detection and to facilitate clearance thereof
WO2011002850A8 (en) Methods of determining the presence and/or concentration of an analyte in a sample
WO2012054648A3 (en) Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
WO2012009578A3 (en) Nanopore-facilitated single molecule detection of nucleic acids
WO2018096182A3 (en) Insertable device for in vivo sensing
GB2490847A (en) Systems and methods for manipulating a molecule in a nanopore
WO2010141719A3 (en) Materials and methods for measuring nitric oxide levels in a biological fluid
WO2009126380A3 (en) Methods and compositions for highly sensitive detection of molecules
WO2008129356A3 (en) Visual attention and emotional response detection and display system
EP2708848A3 (en) System and method for magnetic field data compression
WO2009025852A3 (en) Methods of using mirna for detection of in vivo cell death
EP2372356A4 (en) Sensor chip, biosensor system, method for measuring temperature of biological sample, method for measuring temperature of blood sample, and method for measuring concentration of analyte in blood sample
EP2284526A4 (en) Biosensor system, sensor tip, and method of measuring analyte concentration in blood sample
WO2008109832A3 (en) Viable near-infrared fluorochrome labeled cells and methods of making and using same
EP2392921A4 (en) Method for measuring temperature of biological sample, method for measuring concentration of biological sample, sensor chip and biosensor system
EP2335030A4 (en) System and method for determining volume-related parameters of ocular and other biological tissues
WO2009001862A1 (en) Method of evaluating visceral fat accumulation
EP3320900A3 (en) Marker for determination of sensitivity to anticancer agent
GB2520911A (en) Photobioreactor
WO2014017853A3 (en) Method for inducing blood flow characteristics and mr-signal strength gradient (shear rate) using tof-mra

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11769461

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11769461

Country of ref document: EP

Kind code of ref document: A2